EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Intestinal Fucosylation: A Key Regulatory Hub in Homeostasis and Disease Pathogenesis

Zhishan Xu, Dingbo Song, Fangqi Hu, Qiuhan Liang, Mengyao Zhang, Chao Lei, Jinyuan Li, Haiyi Guo, Zhongbin Deng, Zishan Yang

Biomolecules · 2026

DOI: 10.3390/biom16091226 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biomolecules, 2026. Verfasst von Zhishan Xu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, School of Basic Medical Sciences, Henan Medical University, Xinxiang 453003, China. Hauptthemen laut MEDLINE: Fucose, Inflammatory Bowel Diseases, Intestinal Mucosa, Colorectal Neoplasms. Die Arbeit nennt 174 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Henan Province, Startup Foundation for Doctor of Henan Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inflammatory bowel disease (IBD) and colorectal cancer (CRC) are heterogeneous intestinal disorders that pose significant threats to human health and share common pathological features, including intestinal mucosal barrier disruption and gut microbiota dysbiosis, in which fucosylation acts as a critical regulatory mediator. Fucosylation is a highly conserved post-translational glycosylation modification involving the enzymatic transfer of fucose residues to glycoproteins and glycolipids. This tightly regulated process plays essential roles in maintaining intestinal homeostasis, mediating host–microbiota interactions and regulating immune responses. This review adopts a physiology-to-pathology framework, delineating fucosylation’s operational principles in healthy intestines and its dysregulation in IBD and CRC. It summarizes the spatial distribution of fucosylation, its regulatory mechanisms, and its roles in disease pathogenesis, and also discusses its potential as a diagnostic biomarker and therapeutic target. Finally, this review highlights future research directions to bridge mechanistic insights with clinical translation, emphasizing the promise of fucosylation in the precision diagnosis and treatment of intestinal disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FucoseInflammatory Bowel DiseasesIntestinal MucosaColorectal NeoplasmsHumansHomeostasisGlycosylationAnimalsIntestinal Barrier FunctionGastrointestinal MicrobiomeProtein Processing, Post-Translational

Stichwörter der Autor:innen

colorectal cancerfucosylationgutinflammatory bowel diseasemucosal protection

Substanzen

Fucose

Autor:innen und Institutionen

  • Department of Immunology, School of Basic Medical Sciences, Henan Medical University, Xinxiang 453003, China.
  • Xinxiang Key Laboratory of Tumor Vaccine and Immunotherapy, School of Basic Medical Sciences, Henan Medical University, Xinxiang 453003, China.
  • Department of Surgery, Division of Immunotherapy, University of Louisville, Louisville, KY 40202, USA.
  • Brown Cancer Center, University of Louisville, Louisville, KY 40202, USA.

Förderung

  • Natural Science Foundation of Henan Province
  • Startup Foundation for Doctor of Henan Medical University

Zitieren

APA

Xu, Z., Song, D., Hu, F., Liang, Q., Zhang, M., Lei, C., Li, J., Guo, H., Deng, Z., & Yang, Z. (2026). Intestinal Fucosylation: A Key Regulatory Hub in Homeostasis and Disease Pathogenesis. Biomolecules. https://doi.org/10.3390/biom16091226

Vancouver

Xu Z, Song D, Hu F, Liang Q, Zhang M, Lei C, et al. Intestinal Fucosylation: A Key Regulatory Hub in Homeostasis and Disease Pathogenesis. Biomolecules. 2026. doi:10.3390/biom16091226

BibTeX
@article{Xu2026,
  author = {Xu, Zhishan and Song, Dingbo and Hu, Fangqi and Liang, Qiuhan and Zhang, Mengyao and Lei, Chao and Li, Jinyuan and Guo, Haiyi and Deng, Zhongbin and Yang, Zishan},
  title = {Intestinal Fucosylation: A Key Regulatory Hub in Homeostasis and Disease Pathogenesis},
  journal = {Biomolecules},
  year = {2026},
  doi = {10.3390/biom16091226}
}
Kostenlos starten →